Dexterra Group Inc Stock Price, News & Analysis

Dexterra Group (TSX: DXT) has received TSX approval to renew its Normal Course Issuer Bid (NCIB) program. The new NCIB will run from May 23, 2025 to May 22, 2026, allowing Dexterra to repurchase up to 3,115,173 common shares, representing 5% of outstanding shares. The company can purchase up to 6,566 shares daily, based on 25% of the six-month ADTV of 26,265 shares.

Under its previous NCIB, Dexterra has purchased 2,086,900 shares at an average price of C$7.1921, totaling C$15,009,121.91. The company believes its shares are undervalued and do not reflect its business value and future prospects. Additionally, Dexterra announced an automatic share purchase plan (ASPP) with a designated broker to facilitate share purchases during blackout periods.

Dexterra Group Inc. (TSX: DXT) held its annual and special meeting of shareholders on May 7, 2025, where all nine director nominees were successfully elected to the board. The election results showed strong shareholder support, with most nominees receiving over 99% of votes in favor. Antonia Rossi received the highest approval rate at 99.86%, while Kevin D. Nabholz received the lowest but still strong support at 97.20%. All other matters presented at the meeting were also approved by shareholders.

Dexterra Group Inc. (TSX: DXT) has announced key upcoming dates for shareholders. The company will release its Q1 2025 financial results on May 6, 2025, after market close, followed by a conference call and webcast on May 7, 2025, at 8:30 a.m. Eastern time.

The company's Annual and Special Meeting is scheduled for May 7, 2025, at 10:00 a.m. Eastern time, and will be held in a virtual format via live audio webcast. A presentation related to Q1 results will be available on Dexterra's website prior to the conference call.

Dexterra Group reported strong financial results for 2024, with consolidated revenue reaching $1.0 billion, an 8.1% increase from 2023. The company's Q4 2024 revenue was $247.8 million, up by $16.6 million compared to Q4 2023.

Key financial highlights include:

• Adjusted EBITDA from continuing operations at $107.4 million in 2024
• Support Services achieved record EBITDA of $74.1 million, up 36.8%
• Free Cash Flow improved to $74.7 million, with 69.5% EBITDA conversion
• Net earnings from continuing operations reached $37.5 million
• Earnings per share increased to $0.58 in 2024 from $0.55 in 2023

The company continued its share buyback program, purchasing 1,177,100 shares at an average price of $6.72. A Q1 2025 dividend of $0.0875 per share was declared, payable April 15, 2025.

Dexterra Group Inc. (TSX: DXT) has announced it will release its Q4 2024 financial results on March 6, 2025, after market close. The company will host a conference call and webcast on March 7, 2025, at 8:30 a.m. Eastern Time to discuss the results.

A presentation will be available on the company's website prior to the call. Investors can access the conference call via dial-in number 1-844-763-8274 or watch the live webcast through Dexterra's website. An archived recording will be available until April 6, 2025, using dial-in number 1-855-669-9658 with passcode 3578869.

Dexterra Group reported Q3 2024 results with consolidated revenue of $269.7 million, up 1.5% from Q3 2023. Adjusted EBITDA was $32.0 million, compared to $38.2 million in Q3 2023. Free Cash Flow improved to $11.9 million, up from $10.2 million last year. Net earnings from continuing operations were $13.4 million. The company completed the sale of its Modular business on August 30, 2024, focusing on core Support Services. IFM segment revenue increased 25.2% to $99.7 million, while WAFES revenue decreased to $170.1 million due to normalized wildfire activity.

Dexterra Group Inc. (TSX: DXT) has announced the release date for its Q3 2024 financial results and the details of the accompanying conference call. The company will publish its Q3 2024 results on November 5, 2024, after market close. A conference call and webcast are scheduled for November 6, 2024, at 8:30 a.m. Eastern Time.

Investors can access the conference call by dialing 1-844-763-8274. A live webcast will be available on Dexterra's website at dexterra.com/investor-presentations-events/. The company will also post a presentation on its website on November 5, 2024, for review during the call.

An archived recording of the conference call will be accessible until December 6, 2024, by dialing 1-855-669-9658 with passcode 5076311.

Dexterra Group Inc. (TSX: DXT) has received approval from the Toronto Stock Exchange (TSX) to amend its normal course issuer bid (NCIB), increasing the maximum number of common shares that can be acquired to 3,207,361 or approximately 5.0% of its issued and outstanding shares. The increase, effective October 16, 2024, allows for the repurchase and cancellation of an additional 3,041,761 common shares. Fairfax Financial Holdings , which currently holds about 49.67% of Dexterra's shares, will be permitted to maintain its proportionate interest through the end of 2024.

Dexterra believes that its shares are undervalued and that the NCIB represents an attractive investment opportunity. The company has also announced the continuation of its automatic share purchase plan (ASPP) with a designated broker, allowing for share purchases during blackout periods. The NCIB and ASPP will terminate on the earliest of: reaching the maximum annual purchase limit, NCIB expiration, or Dexterra's termination of the ASPP.